Halozyme Reports Second Quarter 2018 Results

Go back to Halozyme Reports Second Quarter 2018 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 69.25 +0.70 (1.02%)
Previous Close $68.55    52 Week High $18.39 
Open $69.34    52 Week Low $6.96 
Day High $69.81    P/E N/A 
Day Low $68.27    EPS $-0.58 
Volume 435,140